India  

EU medicines regulator launches blood clots probe related to Johnson & Johnson vaccine

Video Credit: Euronews English - Duration: 03:01s - Published
EU medicines regulator launches blood clots probe related to Johnson & Johnson vaccine

EU medicines regulator launches blood clots probe related to Johnson & Johnson vaccine

It comes after the regulator said there was a possible link between very rare cases of blood clots and the AstraZeneca vaccine.


You Might Like


💡 newsR Knowledge: Other News Mentions

European Union European Union Economic and political union of European states

India, EU to re-launch free trade talks: What PM Modi, EU leaders discussed [Video]

India, EU to re-launch free trade talks: What PM Modi, EU leaders discussed

India and the European Union (EU) on Saturday announced their decision to resume negotiations for a balanced and comprehensive trade agreement after a gap of eight years and unveiled an ambitious connectivity partnership, during a virtual meeting between Prime Minister Narendra Modi and leaders of 27 member nations of the bloc. In his remarks, Modi invited the EU to support a proposal by India and South Africa to waive patents on COVID-19 vaccines so that there can be equitable vaccine access for the entire world, officials said. The meeting, participated by leaders of EU member states as well as the top leadership of the EU, also decided to launch negotiations on two other key agreements on investment protection and geographical indications.

Credit: HT Digital Content    Duration: 07:32Published
India, EU agreed to have dedicated dialogues on WTO issues: MEA [Video]

India, EU agreed to have dedicated dialogues on WTO issues: MEA

On economic front, India and EU agreed to have dedicated dialogues on WTO issues, informed Ministry of External Affairs (MEA) Secretary Vikas Swarup on May 08. "On economic front, both sides also agreed to have dedicated dialogues on WTO issues, regulatory cooperation, market access issues and supply chain resilience demonstrating the desire to deepen and further diversify our economic engagement," said MEA Secretary (West).

Credit: ANI    Duration: 01:24Published
Remarkable summit, widened scope of EU-India relationship: EU Commission Chief [Video]

Remarkable summit, widened scope of EU-India relationship: EU Commission Chief

President of the European Commission, Ursula von der Leyen on May 08 said, "It was a remarkable Summit because it widened the scope and the view on the untapped potential in the relationship of the European Union and India." Prime Minister Narendra Modi today also virtually participated in the meeting of EU as a special invitee, on the invitation of Council's President.

Credit: ANI    Duration: 01:10Published
PM Modi invited member states for India-EU High Level Digital Forum: MEA [Video]

PM Modi invited member states for India-EU High Level Digital Forum: MEA

Prime Minister Narendra Modi invited EU member states to participate in India-EU High Level Digital Forum that's likely to be held later this year, informed Ministry of External Affairs (MEA) Secretary Vikas Swarup on May 08. "PM also invited EU member states to participate in India-EU High Level Digital Forum that's likely to be held later this year, to enhance digital cooperation between India and EU via linking of start-ups supporting digital economy and for enhancing investments," said MEA Secretary (West).

Credit: ANI    Duration: 01:15Published

AstraZeneca British-Swedish pharmaceutical company

Age threshold for alternative to AstraZeneca jab raised [Video]

Age threshold for alternative to AstraZeneca jab raised

Under-40s are to be offered an alternative to the Oxford/AstraZeneca Covid-19 vaccine as a precautionary move.

Credit: PA - Press Association STUDIO    Duration: 00:38Published
Under-40s in UK to get alternative Covid jab to AstraZeneca [Video]

Under-40s in UK to get alternative Covid jab to AstraZeneca

Under-40s in the UK will be offered an alternative coronavirus vaccine to the Oxford/AstraZeneca jab. The Joint Committee on Vaccination and Immunisation (JCVI) said there is an "extremely small risk" of people suffering blood clots after having the jab. Report by Thomasl. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 01:00Published

Under-40s to be offered alternative to Oxford jab over blood clot fears

All under-40s are to be offered an alternative to the Oxford/AstraZeneca coronavirus vaccine as a precaution.
Sky News
Vaccine production is truly international collaboration in India: EAM [Video]

Vaccine production is truly international collaboration in India: EAM

Union External Affairs Minister, Dr S Jaishankar attended a virtual conversation, called 'Global Dialogue Series' on May 05. He said, "Our vaccine production situation was different from many other countries. On what basis Covishield was being made in India? It's Oxford-AstraZeneca vaccine, you can say it's British-designed product. It was made in India as the vaccine owner saw India as an efficient production venue. Along with that the ability and approval to make in India, came an obligation to supply it to a large part of the world. So, people have to understand, it was not that vaccine production started in India, it was invented by an Indian, owned by an Indian, produced by an Indian." He further said, "It was a truly international collaboration. When there is an international collaboration, if somebody gave you a vaccine to make in India, then you have to do your part, otherwise, it doesn't work. It also came with support from the Covax initiative. So, there was an obligation to support the Covax initiative to give vaccines at a low cost to a number of nations."

Credit: ANI    Duration: 01:57Published

US 'doing a lot for India' to meet Covid crisis: Joe Biden

President Joe Biden has said that the US was "doing a lot for India" by sending it oxygen and materials to make anti-Covid-19 vaccines. Biden's spokesperson Jen..
IndiaTimes

Related videos from verified sources

Woman In Colorado Treated For Rare Blood Clots Related To Johnson & Johnson COVID Vaccine [Video]

Woman In Colorado Treated For Rare Blood Clots Related To Johnson & Johnson COVID Vaccine

UCHealth has a way to treat patients if they develop blood clots after getting the Johnson and Johnson COVID-19 vaccine.

Credit: CBS 4 Denver     Duration: 02:16Published
Woman successfully treated for extremely rare blood clots after J&J vaccination [Video]

Woman successfully treated for extremely rare blood clots after J&J vaccination

Morgan Wolfe received her Johnson & Johnson COVID-19 vaccine on April 1. But days later she started to feel chills and body aches.

Credit: KDVR     Duration: 01:35Published
New treatment used to care for Denver woman who developed blood clots after J&J vaccine [Video]

New treatment used to care for Denver woman who developed blood clots after J&J vaccine

Nearly one in a half million was Morgan Wolfe’s chances of developing blood clots after receiving the Johnson and Johnson vaccine.

Credit: 7News - The Denver Channel     Duration: 02:24Published